Adi Mor
Director Ejecutivo en CHEMOMAB THERAPEUTICS LTD. .
Fortuna: 18 723 $ al 30/04/2024
Cargos activos de Adi Mor
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
CHEMOMAB THERAPEUTICS LTD. | Director/Miembro de la Junta | 22/09/2011 | - |
Director Ejecutivo | 01/06/2023 | - | |
Director Técnico/Científico/I+D | 22/09/2011 | - | |
Fundador | 22/09/2011 | - | |
Chemomab Ltd.
Chemomab Ltd. BiotechnologyHealth Technology ChemomAb Ltd. develops novel chemokine blocking therapies for inflammatory and fibrotic disorders. It specializes in the development of proprietary monoclonal antibodies, directed towards novel targets, for the treatment of immune-mediated and fibrotic disorders including orphan indications. The company was founded by Adi Mor and Jacob George in 2011 and is headquartered Tel Aviv, Israel. | Director/Miembro de la Junta | 01/01/2011 | - |
Director Ejecutivo | 01/01/2011 | - | |
Director Técnico/Científico/I+D | 01/01/2011 | - | |
Fundador | 01/01/2011 | - |
Historial de carrera de Adi Mor
Formación de Adi Mor.
Tel-Aviv University | Doctorate Degree |
Estadísticas
Internacional
Israel | 4 |
Operativa
Director/Board Member | 2 |
Chief Executive Officer | 2 |
Chief Tech/Sci/R&D Officer | 2 |
Sectorial
Health Technology | 3 |
Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
CHEMOMAB THERAPEUTICS LTD. | Health Technology |
Empresas privadas | 1 |
---|---|
Chemomab Ltd.
Chemomab Ltd. BiotechnologyHealth Technology ChemomAb Ltd. develops novel chemokine blocking therapies for inflammatory and fibrotic disorders. It specializes in the development of proprietary monoclonal antibodies, directed towards novel targets, for the treatment of immune-mediated and fibrotic disorders including orphan indications. The company was founded by Adi Mor and Jacob George in 2011 and is headquartered Tel Aviv, Israel. | Health Technology |
- Bolsa de valores
- Insiders
- Adi Mor
- Experiencia